Akanda Corp.(AKAN)

Drug Manufacturers - Specialty & Generic · Toronto, ON

$1.96+0.05 (+2.62%)

Delayed quote: Oct 6, 2026, 9:44 AM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T13:45:27.914Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:45:27.914Z.

Quote observation: 2026-10-06T13:44:40.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 1.96
Unrounded diluted TTM EPS · period ending 2026-06-30: N/A

FMP input reference: 76b909c1583fef9061a4d716d1bfa7e8c39158eca830282836b9decd9e758125

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

AKAN PE Ratio Metrics

PE RATIO

N/A

AKAN Competitors' PE Ratio

AKAN

Akanda Corp.

Current

Market Cap

$63437.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCWB

HCW Biologics Inc.

vs AKAN

Market Cap

$559702.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDT

CDT Equity Inc.

vs AKAN

Market Cap

$687644.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BJDX

Bluejay Diagnostics, Inc.

vs AKAN

Market Cap

$814320.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BBLG

Bone Biologics Corporation

vs AKAN

Market Cap

$868982.00

PE Ratio

N/A

TTM Avg

0.00

3Y Avg

0.00

5Y Avg

0.00

DCOY

Decoy Therapeutics Inc.

vs AKAN

Market Cap

$875087.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GCTK

GlucoTrack, Inc.

vs AKAN

Market Cap

$889929.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ASBP

Aspire Biopharma Holdings, Inc.

vs AKAN

Market Cap

$1.02M

PE Ratio

N/A

TTM Avg

173046.93

3Y Avg

281427.36

5Y Avg

281427.36

CMND

Clearmind Medicine Inc.

vs AKAN

Market Cap

$1.08M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HKPD

Cellyan Biotechnology Co., Ltd

vs AKAN

Market Cap

$1.11M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Akanda Corp. (AKAN)	$63437.00	N/A	N/A	N/A	N/A
HCW Biologics Inc. (HCWB)vs ›	$559702.00	N/A	N/A	N/A	N/A
CDT Equity Inc. (CDT)vs ›	$687644.00	N/A	N/A	N/A	N/A
Bluejay Diagnostics, Inc. (BJDX)vs ›	$814320.00	N/A	N/A	N/A	N/A
Bone Biologics Corporation (BBLG)vs ›	$868982.00	N/A	0.00	0.00	0.00
Decoy Therapeutics Inc. (DCOY)vs ›	$875087.00	N/A	N/A	N/A	N/A
GlucoTrack, Inc. (GCTK)vs ›	$889929.00	N/A	N/A	N/A	N/A
Aspire Biopharma Holdings, Inc. (ASBP)vs ›	$1.02M	N/A	173046.93	281427.36	281427.36
Clearmind Medicine Inc. (CMND)vs ›	$1.08M	N/A	N/A	N/A	N/A
Cellyan Biotechnology Co., Ltd (HKPD)vs ›	$1.11M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

AKAN PE Ratio Metrics

AKAN Competitors' PE Ratio

P/E Comparison

PE Ratio Formula & Definition

Related Metrics